WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001087970) A NOVEL POLYPEPTIDE, HUMAN TYROSINASE 12 AND THE POLYNUCLEOTIDE ENCODING THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/087970    International Application No.:    PCT/CN2001/000719
Publication Date: 22.11.2001 International Filing Date: 08.05.2001
IPC:
C12N 9/02 (2006.01)
Applicants: SHANGHAI BIOWINDOW GENE DEVELOPMENT INC. [CN/CN]; 12th Floor, 3rd Building 1111 Zhongshan Bei Er Road Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: SHANGHAI HUA DONG PATENT AGENCY; 319 Yue Yang Road Shanghai 200031 (CN)
Priority Data:
00 1 15651.9 09.05.2000 CN
Title (EN) A NOVEL POLYPEPTIDE, HUMAN TYROSINASE 12 AND THE POLYNUCLEOTIDE ENCODING THEREOF
(FR) POLYPEPTIDE DE TYROSINASE 12 HUMAINE, ET POLYNUCLEOTIDE LE CODANT
Abstract: front page image
(EN)The invention discloses a novel polypeptide, human tyrosinase 12, the polynucleotide encoding the same and the method of production thereof by DNA recombinant techniques. Methods of using the polypeptide for treating various diseases such as malignant tumors, hemopathy, HIV infection, immune diseases, and various inflammations are also disclosed. Furthermore, the invention discloses the antagonists of the polypeptide and the effects thereof. The use of the polynucleotide encoding the novel human tyrosinase 12 is also disclosed.
(FR)L'invention concerne un polypeptide de tyrosinase 12 humaine, le polynucléotide qui la code et un procédé de production de ce polypeptide à l'aide de technologie de recombinaison de l'ADN. Elle concerne aussi un méthode traitement de troubles variés, tels que tumeur maligne, hémopathie, infection VIH, maladie immunologique, inflammations variées, et d'autres. Elle concerne encore les antagonistes du polypeptide et leurs effets thérapeutiques. Elle concerne enfin l'utilisation du polynucléotide codant la tyrosinase 12 humaine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)